Advertisement
Canada markets open in 6 hours 12 minutes
  • S&P/TSX

    21,728.55
    +14.01 (+0.06%)
     
  • S&P 500

    5,018.39
    -17.30 (-0.34%)
     
  • DOW

    37,903.29
    +87.37 (+0.23%)
     
  • CAD/USD

    0.7289
    +0.0008 (+0.11%)
     
  • CRUDE OIL

    79.41
    +0.41 (+0.52%)
     
  • Bitcoin CAD

    79,222.54
    -1,146.30 (-1.43%)
     
  • CMC Crypto 200

    1,262.73
    -8.01 (-0.63%)
     
  • GOLD FUTURES

    2,322.10
    +11.10 (+0.48%)
     
  • RUSSELL 2000

    1,980.23
    +6.32 (+0.32%)
     
  • 10-Yr Bond

    4.5950
    -0.0910 (-1.94%)
     
  • NASDAQ futures

    17,539.75
    +101.50 (+0.58%)
     
  • VOLATILITY

    15.39
    0.00 (0.00%)
     
  • FTSE

    8,146.30
    +25.06 (+0.31%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • CAD/EUR

    0.6800
    +0.0007 (+0.10%)
     

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

Buy Voyager Stock, Analyst Says. The Little Biotech Could Have Big Breakthroughs.

Voyager Therapeutics has surely tried investors’ patience since it came public eight years ago. The biotech firm’s stock has fallen as low as $2.50 from a peak of $30, as its early programs to treat neurological diseases didn’t pan out. Analysts at Guggenheim Securities initiated coverage of the Lexington, Mass.-based biotech with a Buy rating earlier this week.